Career history of Yu Ren Wang
Former positions of Yu Ren Wang
Companies | Position | Start | End |
---|---|---|---|
ADAGENE INC. | Corporate Officer/Principal | 2019-08-31 | 2022-12-31 |
Jemincare Therapeutics Corp.
Jemincare Therapeutics Corp. BiotechnologyHealth Technology Jemincare Therapeutics Corp. is a pharmaceutical company. It plans to in license the global and China rights of the large and small molecule clinical stage programs in therapeutic areas such as oncology, cardiovascular and kidney disease. The company was founded by John Xu in November 2018 and is headquartered in Princeton, NJ. | Chief Tech/Sci/R&D Officer | 2018-11-30 | 2019-07-31 |
Reaction Biology Corp.
Reaction Biology Corp. Miscellaneous Commercial ServicesCommercial Services Reaction Biology Corp. specializes in kinase and epigenetic HTS and profiling services. It offers radiolabeled biochemical assays available for multiple enzyme classes including: Kinase Assays, HMT Assays, and HDAC Assays. Its products include Methyltransferase, IDH proteins, Apoptosis, DNA Demethylation, Apoptosis and NQOs. The company was founded by Scott L. Diamond in 2001 and is headquartered in Malvern, PA. | Corporate Officer/Principal | 2013-02-28 | 2018-11-30 |
Training of Yu Ren Wang
Shandong Agricultural University | Undergraduate Degree |
Chinese Academy of Agricultural Sciences | Graduate Degree |
University of Pennsylvania | Doctorate Degree |
Statistics
International
United States | 4 |
China | 4 |
Operational
Corporate Officer/Principal | 2 |
Chief Tech/Sci/R&D Officer | 1 |
Undergraduate Degree | 1 |
Sectoral
Consumer Services | 4 |
Health Technology | 3 |
Commercial Services | 2 |
Positions held
Active
Inactive
Listed companies
Private companies
Linked companies
Listed companies | 1 |
---|---|
ADAGENE INC. | Health Technology |
Private companies | 2 |
---|---|
Reaction Biology Corp.
Reaction Biology Corp. Miscellaneous Commercial ServicesCommercial Services Reaction Biology Corp. specializes in kinase and epigenetic HTS and profiling services. It offers radiolabeled biochemical assays available for multiple enzyme classes including: Kinase Assays, HMT Assays, and HDAC Assays. Its products include Methyltransferase, IDH proteins, Apoptosis, DNA Demethylation, Apoptosis and NQOs. The company was founded by Scott L. Diamond in 2001 and is headquartered in Malvern, PA. | Commercial Services |
Jemincare Therapeutics Corp.
Jemincare Therapeutics Corp. BiotechnologyHealth Technology Jemincare Therapeutics Corp. is a pharmaceutical company. It plans to in license the global and China rights of the large and small molecule clinical stage programs in therapeutic areas such as oncology, cardiovascular and kidney disease. The company was founded by John Xu in November 2018 and is headquartered in Princeton, NJ. | Health Technology |
- Stock Market
- Insiders
- Yu Ren Wang
- Experience